Press Release Archive

Alphabetical (index by companies).

0-9

Press Releases from Greystone Research Associates: (30 total)

1.	Self-Monitoring for Hypertension Patients Growing as Technology and Devices Improve
2.	As Variable Dosing for Injectable Drugs Increases, Devices Strive to Keep Pace
3.	Technology Gains Renewing Interest in Needle Arrays as Drug Delivery Devices
4.	Drug Delivery Pen Injectors Growing by Providing Key Benefits to Both Suppliers and End Users
5.	Insulin Patch Pumps Proliferating, Creating New Options for Controlling Diabetes
6.	Projected Growth of Diabetes Patient Population Driving the Appearance of Numerous Pipeline Glucose Monitors
7.	Inhaled Antibiotics and Antivirals Creating Treatment Options for Caregivers and Patients
8.	Extended Release Drugs for Neurology Providing Caregivers and their Patients with Valuable Options
9.	Demographics and Improving Technology to Provide Coagulation Self-Testing with Plenty of Upside
10.	Demographics of Several CNS Indications Position Transdermal Drugs for Growth
11.	Patient Self-Monitoring Positioned for Growth
12.	Advantages of Administering Pain Drugs via Inhalation Go Beyond Convenience
13.	Transmucosal Drug Delivery Gaining Interest in Niche Markets
14.	New-Generation Transdermal Drug Patches Relying on Technology Convergence to Achieve Targets
15.	Microneedle Drug Delivery Systems Moving Toward Commercialization by Converging with Existing Delivery Technologies
16.	Share of Injectables Supplied in Drug Cartridges Continues to Increase
17.	Prefilled Syringes to Reach 4.35 Billion Units in 2015 According to Greystone Research
18.	Active Transdermal Delivery Growth Being Driven by Technology Convergence
19.	Growth of Needle-free Injection Hinges on Penetrating Niche Markets
20.	Drug Delivery Coatings Creating Opportunities for Developers and Practitioners
21.	Dry Powder Inhalation Expanding in Established Markets while Pursuing New Therapeutic Targets
22.	Drug Solubilization Technologies Creating Options for Developers
23.	Autoinjectors Creating Opportunities for Drug Marketers
24.	Point-of-Delivery Drug Reconstitution Systems Growing by Simplifying the Safe Administration of Lyophilized Drugs, According to Greystone Research
25.	Therapeutic Proteins to Reach $103 Billion by 2014, According to Greystone Research
26.	Synthetic Endovascular Repair Systems to Top $2 Billion by 2013, Says Greystone Research
27.	Specialty Injectable Drugs to Top $90 Billion by 2014, According to Greystone Research
28.	Therapeutic Microneedles to Exceed $400 Million in 2013, Says Greystone Research
29.	Wireless Hospital Monitors to Exceed $600 Million in 2013, According to Greystone Research
30.	Dominance of Patient Self-Administration in Key Disease Segments Increasing, Finds Greystone Research

0-9

To top

Your Press Releases on
Google News